在HMA加上venetoclax失败时的新疗法
1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
用venetoclax (HMA-VEN) 治疗转化性急性髓性白血病的低甲基化剂. 然而,治疗失败和复发仍然存在,特别是TP53突变,需要新的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 低甲基化剂与venetoclax (HMA-VEN) 的组合代表了治疗新诊断的急性髓性白血病 (AML) 的重大进展.
- 尽管HMA-VEN的疗效,治疗失败和复发仍然是影响患者生存的关键挑战.
- TP53突变与初级诱导失败有关,并预测AML患者的结果不佳.
研究的目的:
- 审查AML中HMA-VEN治疗的当前情况.
- 讨论venetoclax耐药性的机制,特别是与TP53.3等遗传突变相关的机制.
- 探索管理HMA-VEN失败和复发的策略,包括重新挑战,临床试验和新兴疗法.
主要方法:
- 对AML中HMA-VEN治疗的临床前数据和临床发现的审查.
- 分析遗传突变,如TP53在venetoclax耐药性中的作用.
- 讨论HMA-VEN失败或复发的患者的治疗策略.
主要成果:
- TP53突变通过上调抗瘤蛋白质 (MCL-1,BCLXL) 来促进venetoclax耐药性.
- 对于因疾病进展以外的其他原因停止治疗的患者,可以考虑重新使用HMA-VEN.
- 对于在HMA-VEN治疗中进展的患者,使用新药或强化化疗的临床试验是首选选择.
结论:
- 维尼托克拉克斯耐药性是AML的重大临床障碍,通常是由遗传变异驱动的.
- 对HMA-VEN衰竭的管理需要个性化的方法,优先考虑临床试验和新的治疗组合.
- 新兴疗法侧重于克服抵抗机制,准白血病发生,并利用免疫疗法消除AML.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

